Hi Prog., While we all know this latest PR is good news, we also know it was the 1st cohort with minimal administered dosage. A tox reaction was not expected at this beginging level. Now a doubling of dosage will be interesting, as well as the lab results of such.

I expect we will have a small pop, and then the usual setteling in sp as most of us are already 'All In' and the rest of the watchers, yet uncommitted, will probably wait a bit longer as they are a squimish bunch needing more confirmation before dipping the toe in the water.

CTIX is the best deal out there that I know of in any Bio-Pharma co. for a 'Risk to Reward' basis on a $1.00 bet. For the life of me I can't understand how we can now be trading less than 500K daily, (except being 'under-the-radar), however I believe that will change after a 2nd cohort passage on Kevetrin.

-JMO- and I welcome everyones elses.

-bunny-